Cost-Effectiveness Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine Program for the Elderly Aged 60 Years or Older in Shanghai, China

• Main Authors: Xiaodong Sun (Author), Yuekun Tang (Author), Xiaoying Ma (Author), Xiang Guo (Author), Zhuoying Huang (Author), Jia Ren (Author), Jing Qiu (Author), Hongli Jiang (Author), Yihan Lu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The pneumococcal vaccine has been considered as the most effective measure to prevent pneumococcal diseases. In 2013, Shanghai launched a major public health program to vaccinate people aged 60 years or older with 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV-23) free of charge. By...